Obsidian to Present Melanoma Therapy Data at November Conference
Obsidian will present data on its melanoma therapy at a November conference, marking the next disclosure point for its cutaneous melanoma program.
Topic
Obsidian Therapeutics
Topic
Obsidian Therapeutics
Obsidian to Present Updated Amsoki-cel Phase 1/2 Melanoma Data at SITC 2026
Obsidian Therapeutics will present updated Phase 1/2 data on amsoki-cel (OBX-115), its engineered TIL therapy, in advanced melano…